Near-Infrared Perfusion During Minimally Invasive Thoracic Surgery Download
This will be a prospective, (NSR), single-center feasibility study of the Olympus VE2 NIR Imaging System to assess perfusion using NIR during minimally invasive esophagectomy and pulmonary segmentectomy. The aims of the study are: 1\. To utilize NIR intraoperative imaging with the Olympus VE2 NIR Imaging System to: i. Characterize gastric conduit perfusion during esophagectomy and, ii. Identify segmental anatomy during sublobar pulmonary resection (segmentectomy) after intraoperative, intravenous delivery of low-dose 0.15 mg/kg of ICG.
Checked against the public recordLast updated Nov 26, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Other
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Sponsor
- Massachusetts General Hospital
- Interventions being studied
- Device: Olympus VE2 NIR Imaging System; Drug: Indocyanine green
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: -Subject has a suspicious lung lesion for which a minimally invasive segmentectomy is planned -OR- sub-ject has an esophageal lesion for which an esophagectomy is planned - * Subject is 18 years of age or older * Subject is willing and able to provide informed consent Exclusion Criteria: * Subject is not eligible for surgical resection as determined by the treating physician * Subject has known or suspected allergy to Iodine, shellfish or intravenous contrast * Subject is not eligible or considered high risk for surgical resection as determined by pre-operative spirometry * Subject is female and of childbearing age who is currently pregnant or who is planning to become pregnant within the study * Subject is unable and unwilling to provide informed consent * Subject has liver disease or is taking drugs impact liver metabolism.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Massachusetts General HospitalBoston, Massachusetts
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 26, 2025. Always confirm current availability with the study team.